Clinical Trial Update: LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

View source ↗

Summary

Completed the LOTRONEX (alosetron) trial for severe diarrhea-predominant irritable bowel syndrome (IBS-D) sponsored by Prometheus Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• LOTRONEX (alosetron hydrochloride)

Snippet

Sponsor: Prometheus Laboratories | Conditions: Irritable Bowel Syndrome | Status: COMPLETED